Cleo Diagnostics Ltd Cash Flow-to-Debt Ratio
Cleo Diagnostics Ltd cash flow-to-debt ratio. Cleo Diagnostics Ltd (COV) has a Cash Flow-to-Debt Ratio of -1.47x as of December 2025, meaning its operating cash flow of AU$-1.67 Million could theoretically repay -1% of its total liabilities (AU$1.14 Million) in one year. See Cleo Diagnostics Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Cleo Diagnostics Ltd (2023–2025)
Cash flow-to-debt ratio of Cleo Diagnostics Ltd from 2023 to 2025. Historical debt coverage capacity for Cleo Diagnostics Ltd across 3 annual periods. Also explore net asset momentum of Cleo Diagnostics Ltd to track the company's year-over-year net asset growth rate.
Cleo Diagnostics Ltd Cash Flow-to-Debt Ratio by Year (2023–2025)
Cleo Diagnostics Ltd cash flow-to-debt ratio by year from 2023 to 2025. Year-by-year debt coverage analysis for Cleo Diagnostics Ltd. For the full cash flow conversion analysis, see COV operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.63x | AU$-2.90 Million | AU$1.10 Million | ▲ +36.9% |
| 2024 | -4.18x | AU$-2.03 Million | AU$486.22K | ▼ -1132.3% |
| 2023 | -0.34x | AU$-684.47K | AU$2.02 Million | — |